Is There a Role for Hyperbaric Oxygen Therapy in Reducing Long-Term COVID-19 Sequelae?

Author:

Oliaei Shahram1,Paranjkhoo Parinaz2,SeyedAlinaghi SeyedAhmad3ORCID,Mehraeen Esmaeil4ORCID,Hackett Daniel5ORCID

Affiliation:

1. HBOT Research Center, Golestan Hospital, Airspace and Diving Medicine Faculty, Navy and AJA Medical University, Tehran 166861955, Iran

2. Turpanjian College of Health Sciences, American University of Armenia, Yerevan 0019, Armenia

3. Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran 1419733141, Iran

4. Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal 5681761351, Iran

5. Physical Activity, Lifestyle, Ageing and Wellbeing Faculty Research Group, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia

Abstract

The COVID-19 pandemic has plagued our society for approximately three years [...]

Publisher

MDPI AG

Subject

General Medicine

Reference12 articles.

1. Mucormycosis infection in patients with COVID-19: A systematic review;SeyedAlinaghi;Health Sci. Rep.,2022

2. COVID-19 mortality and its predictors in the elderly: A systematic review;Dadras;Health Sci. Rep.,2022

3. Design, development, and evaluation of a registry system for hyperbaric oxygen therapy: A methodological study;Oliaei;Health Sci. Rep.,2022

4. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): A systematic review;Oliaei;Eur. J. Med. Res.,2021

5. (2022, December 06). NIH COVID-19 Treatment Guidelines: Oxygenation and Ventilation for Adults, Available online: https://www.covid19treatmentguidelines.nih.gov/management/critical-care-for-adults/oxygenation-and-ventilation-for-adults/#:~:text=The%20optimal%20oxygen%20saturation%20measured,%3E96%25%20may%20be%20harmful.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3